Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

827 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 827 results

Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Not applicableUnknownNCT03739177
What this trial is testing

Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients

Who this might be right for
Bladder Cancer
Animated Dynamics, Inc. 150
Testing effectiveness (Phase 2)UnknownNCT04813107
What this trial is testing

Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 79
Very early researchLooking for participantsNCT07531264
What this trial is testing

EMG-guided Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Human-Machine Interaction

Who this might be right for
StrokeChronic StrokeHemiparetic Stroke
University of Houston 48
Early research (Phase 1)Not Yet RecruitingNCT07053735
What this trial is testing

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Peking University First Hospital 30
Not applicableNot Yet RecruitingNCT07074964
What this trial is testing

Manual Therapy in Vagus Nerve Neuromodulation for the Treatment of Bruxism

Who this might be right for
Bruxism, Sleep
Escoles Universitaries Gimbernat 40
Large-scale testing (Phase 3)UnknownNCT01225614
What this trial is testing

Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive

Who this might be right for
MyopathyMuscular WeaknessRespiratory Insufficiency
Assistance Publique - Hôpitaux de Paris 77
Testing effectiveness (Phase 2)Looking for participantsNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268339
What this trial is testing

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

Who this might be right for
High-Risk Non-Muscle Invasive Bladder Cancer
The Christie NHS Foundation Trust 328
Not applicableStudy completedNCT06818799
What this trial is testing

Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Transitional Cell Carcinoma
Helwan University 50
Not applicableEnded earlyNCT06026332
What this trial is testing

ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Who this might be right for
Bladder Cancer
Ferring Pharmaceuticals 202
Testing effectiveness (Phase 2)Looking for participantsNCT05024734
What this trial is testing

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

Who this might be right for
Bladder CancerNon-muscle Invasive
Roland Seiler-Blarer 34
Not applicableNot Yet RecruitingNCT06678633
What this trial is testing

T-Control® Safety for Cytostatics Management

Who this might be right for
Non-muscle-invasive Bladder Cancer
Rethink Medical SL 16
Early research (Phase 1)Looking for participantsNCT06632964
What this trial is testing

A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
The Affiliated Hospital of Xuzhou Medical University 16
Testing effectiveness (Phase 2)UnknownNCT03620435
What this trial is testing

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

Who this might be right for
Safety Issues
McGill University Health Centre/Research Institute of the McGill University Health Centre 25
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Not applicableStudy completedNCT02942121
What this trial is testing

Application-based Perioperative Management of the Radical Cystectomy Patient

Who this might be right for
Bladder Cancer
University of Kansas Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00318643
What this trial is testing

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
Halozyme Therapeutics 27
Load More Results